Our findings of an anti-inflammatory monocyte cluster that is increased in COVID-19 patients, along with suppressive/tissue-repair gene expression changes in monocytes that are accentuated in progressive patients (including CD163, IL1R2, AREG, MRC1, HAVCR2, LGALS9, IL10), support the former evidence. This evidence concerns the gene MRC1 and COVID-19.